Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: JAMA Intern Med. 2015 Apr 1;175(4):531–539. doi: 10.1001/jamainternmed.2014.8063

Table 2.

Reduced Models of the Adjusted HRs and Medians for Total VMS Duration and Post-FMP Persistencea

Total VMS Duration
(n = 1368)
Post-FM P Persistence
(n = 772)


Predictor HR (95% CI)b Median
Duration, y
P Value HR (95% CI)b Median
Persistence, y
P Value
Age, yc

  42.0–44.9 1 [Reference] >10.90 <.005 NAd NA .05


  45.0–49.9 2.43 (1.30–4.51) 9.34 1 [Reference]e 6.76


  50.0–54.9 2.71 (1.44–5.09) 7.73 1.16 (0.84–1.60) 5.72


  ≥55.0 3.60 (1.78–7.29) 6.42 1.53 (1.05–2.24) 4.48

Menopausal transition stage

  Premenopause 1 [Reference] >10.90 <.001 1 [Reference] >10.43 .001


  Early perimenopause 2.04 (1.35–3.11) 10.06 1.48 (0.89–2.27) 6.61


  Late perimenopause 3.55 (2.26–5.60) 6.12 2.16 (1.33–3.49) 4.47


  Postmenopause 3.74 (2.34–5.98) 5.66 2.04 (1.27–3.28) 4.59

Race/ethnicity

  Non-Hispanic white 1 [Reference] 9.01 <.008 1 [Reference] 5.43 .048


  African American 0.75 (0.58–0.96) >10.90 0.79 (0.60–1.04) 6.88


  Chinese 1.80 (1.17–2.76) 5.45 1.84 (1.14–2.95) 3.05


  Hispanic 1.97 (0.56–6.92) 4.78 1.06 (0.19–5.84) 4.92


  Japanese 1.00 (0.66–1.51) 9.34 0.91 (0.57–1.45) 5.77

Educational level ≥college

  No 1 [Reference] 9.93 .03 1 [Reference] 6.54 .003


  Yes 1.25 (1.03–1.52) 7.66 1.40 (1.13–1.74) 4.54

Symptom sensitivity at first annual follow-upf

  Very low 1 [Reference] 7.36 .05 1 [Reference] 4.38 .049


  Low 0.77 (0.58–1.00) 9.57 0.76 (0.56–1.04) 5.48


  Moderate 0.85 (0.64–1.13) 8.22 0.78 (0.57–1.07) 5.45


  High 0.64 (0.46–0.89) 10.81 0.58 (0.39–0.85) 8.47

Anxiety score ≥4c

  No NA NA NA 1 [Reference] 4.96 .02


  Yes NA NA 0.73 (0.56–0.95) 7.40

Perceived stressc,g

  Never or almost never 1 [Reference] 8.00 .02 1 [Reference] 4.92 .008


  At least sometimes 0.75 (0.58–0.96) 10.78 0.70 (0.54–0.91) 8.13

Depressive symptoms on the CES-D Scale ≥16c

  No 1 [Reference] 7.73 .005 NA NA NA


  Yes 0.66 (0.50–0.88) >10.90 NA NA

Abbreviations: CES-D, Center for Epidemiologic Studies–Depression; FMP, final menstrual period; HR, hazard ratio; NA, not applicable; VMS, vasomotor symptoms.

a

Adjusted for all variables listed and for site. The total sample sizes are smaller than those in Table 1 because of missing data for some covariates.

b

Compared with the reference group, an HR exceeding 1.0 indicates shorter duration, an HR of less than 1.0 indicates longer duration, and an HR of 1.0 indicates no difference in duration.

c

At first VMS report for VMS duration and at first post-FMP report of frequent VMS for post-FMP persistence.

d

This variable was omitted in the backward elimination analysis.

e

Because the number of women in the age category of 42.0 to 44.9 years was very small for post-FMP persistence, the 2 lowest age categories were combined so that the reference category was up to age 49.9 years.

f

Very low is below the mean −1 SD (<6.9), low is between the mean and −1 SD (7.0–10.4), moderate is between the mean and 1 SD (10.5–13.8), and high is above the mean +1 SD (>13.8).

g

A score between 5 and 10 is never or almost never, and a score between 11 and 25 is at least sometimes.

HHS Vulnerability Disclosure